Wisconsin Alumni Research Foundation

Cellectar Reports Financial Results for Year Ended 2022 and Provides a Corporate Update

Retrieved on: 
Thursday, March 9, 2023
Macroglobulinemia, BCMA, Neoplasm, CLR, Wisconsin Alumni Research Foundation, Primary central nervous system lymphoma, NCI, State Administrative Expenses, Cash, Development, Diagnosis, Glioma, District court, Tat, Conference, Lead, DRS, Patient, Research, Hand, PLE, G&A, Cancer, Lymphoma, Comment, Travel, Marketing, Society, CNS, Intellectual property, Pharmaceutical industry, Cryptocurrency

FLORHAM PARK, N.J., March 09, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, today announced financial results for the year ended December 31, 2022 and provided a corporate update.

Key Points: 
  • FLORHAM PARK, N.J., March 09, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, today announced financial results for the year ended December 31, 2022 and provided a corporate update.
  • Presented preclinical data on the CLR 12120 series of targeted alpha therapies (TATs) at the 13th Annual World ADC Conference.
  • Net cash used in operating activities during the year ended December 31, 2022 was approximately $25.2 million.
  • Research and Development Expense: R&D expense for the year ended December 31, 2022 was approximately $19.2 million, compared to approximately $17.6 million for the year ended December 31, 2021.

Cellectar Announces Resolution of Breach of Contract and Intellectual Property Dispute

Retrieved on: 
Wednesday, November 16, 2022
Marketing, COVID-19, Exchange, PLE, Sarcoma, Diagnosis, Wisconsin Alumni Research Foundation, Peptide, Risk, PDC, Safety, Patient, Regulation, Neuroblastoma, Drug discovery, Security (finance), Lymphoma, District court, News, Cancer, DRS, Research, Intellectual property, Christian democracy, Brain, FDA, WM, Pharmaceutical industry

Jamey Weichert and Anatoly Pinchuk have resolved a lawsuit filed by Cellectar in October 2021 in the United States District Court for the Western District of Wisconsin concerning employee contracts and intellectual property rights in certain intellectual property pertaining to the diagnosis and treatment of cancer.

Key Points: 
  • Jamey Weichert and Anatoly Pinchuk have resolved a lawsuit filed by Cellectar in October 2021 in the United States District Court for the Western District of Wisconsin concerning employee contracts and intellectual property rights in certain intellectual property pertaining to the diagnosis and treatment of cancer.
  • The foregoing parties cannot further comment on that resolution, except to note that (i) all claims against Drs.
  • Weichert and Pinchuk have been voluntarily dismissed, and (ii) Cellectar has secured an irrevocable, non-exclusive license to the patents at issue in the lawsuit.
  • The company has established exclusivity on a broad U.S. and international intellectual property rights portfolio around its proprietary cancer-targeting PLE technology platform, including iopofosine and its PDC programs.

FitStack, a new solution for code and container risk management, launches with support from Varsity Venture Studio

Retrieved on: 
Tuesday, November 1, 2022
DRS, WARF, CEO, Software as a service, Organization, Research, Risk, Department, Privacy, UP Diliman Department of Computer Science, Technology, Risk management, University, University of Wisconsin–Madison, Computer Sciences, Machine learning, Evidence, Wisconsin Alumni Research Foundation, Environment, Cummings, CICD, Management, Varsity

MADISON, Wis., Nov. 1, 2022 /PRNewswire/ -- Today Varsity Venture Studio – a collaborative venture studio between the University of Wisconsin-Madison, the Wisconsin Alumni Research Foundation (WARF) and venture builder High Alpha Innovation – announced the public launch of FitStack (www.fitstack.dev), a proactive risk management solution for application development teams to address the ongoing challenges in managing software supply chain security.

Key Points: 
  • "Roger and Mohannad's solution to such a pressing problem is the perfect fit for building a startup via Varsity Venture Studio."
  • Varsity Venture Studio, a University of Wisconsin-Madison-wide venture studio, turns ideas into funded software businesses.
  • Varsity Venture Studio is a collaboration between the University of Wisconsin-Madison, Wisconsin Alumni Research Foundation (WARF) and venture builder High Alpha Innovation, and is the first university venture studio of its kind.
  • Learn more about Varsity Venture Studio at varsityventurestudio.com , High Alpha Innovation at highalphainno.com , and about WARF at warf.org .

Marvell Announces the Appointment of Rebecca House to Board of Directors

Retrieved on: 
Monday, August 22, 2022
People, University, CEO, Technology, Wisconsin Alumni Research Foundation, MRVL, NASDAQ, LLP, WARF, Solution, Board, House, Foley, Ethics, Senior, Rockwell Automation, Harley-Davidson, University of Wisconsin–Madison, Compliance, Marvell, Assistant, Foley & Lardner, Name, Harvard Law School, Management

SANTA CLARA, Calif., Aug. 22, 2022 /PRNewswire/ -- Marvell (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, has appointed Rebecca (Becky) House, Senior Vice President, Chief People and Legal Officer and Secretary of Rockwell Automation, Inc., to its board of directors.

Key Points: 
  • SANTA CLARA, Calif., Aug. 22, 2022 /PRNewswire/ -- Marvell (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, has appointed Rebecca (Becky) House, Senior Vice President, Chief People and Legal Officer and Secretary of Rockwell Automation, Inc., to its board of directors.
  • "Her insights and counsel will be very valuable as we continue to scale and grow Marvell's business globally."
  • Ms. House is also on the board of directors for FMI Funds, Inc., MIND Research Institute and the Wisconsin Alumni Research Foundation (WARF).
  • She is a director and former Board President of Sojourner Family Peace Center, the largest provider of domestic violence services in the state of Wisconsin.

Ortek's Electronic Cavity Detection Device Receives 20th Global Patent

Retrieved on: 
Tuesday, May 17, 2022
People, ECD, Tooth decay, Disease, Pain, Radiation, Wisconsin Alumni Research Foundation, Multimedia, Patient, View, Therapy, Patent, FDA, United Kingdom, State university system, Dentistry, Republic, Stony Brook University School of Dental Medicine, State University of New York, Conditional sentence, Dentist, Technology, X-ray, Medical device

ROSLYN HEIGHTS, N.Y., May 17, 2022 /PRNewswire/ -- Ortek Therapeutics, Inc., a leader in developing and commercializing novel oral care technologies, today announced that the Brazilian Patent and Trademark Office has issued a patent covering the Ortek-ECD®, a revolutionary electronic cavity detection device that can detect tooth decay often missed by X-rays.

Key Points: 
  • ROSLYN HEIGHTS, N.Y., May 17, 2022 /PRNewswire/ --Ortek Therapeutics, Inc., a leader in developing and commercializing novel oral care technologies, today announced that the Brazilian Patent and Trademark Office has issued a patent covering the Ortek-ECD, a revolutionary electronic cavity detection device that can detect tooth decay often missed by X-rays.
  • Tooth decay is the world's most common chronic disease and affects an estimated 2.3 billion people worldwide.
  • Ortek has entered into an exclusive worldwide license to the ECD patents with The Research Foundation for The State University of New York.
  • Ortek Therapeutics, Inc. is a global leader in developing and commercializing cutting-edge oral care technologies.

Vista360, LLC Promotes Lela Harris to Partner - Firm celebrates 20th Anniversary and Success of Bloom360 Learning Community

Retrieved on: 
Thursday, April 28, 2022
Volunteering, Learners, Time, Director, LLC, Education, Learning, Child, Mentorship, Organization, Partnership, Wisconsin Alumni Research Foundation, Goal, Creativity, News, Research, Marquette University, Board, Mindfulness, Industry, Compliance, EAST, Lela, Tutoring, Financial adviser, Partner

EAST TROY, Mich., April 28, 2022  /PRNewswire-PRWeb/ -- Vista360, a management consulting firm celebrating 20 years in business in 2022, today announced that senior consultant, Lela Harris, has been promoted to Partner. Vista360 serves a nationwide client base of investment advisers and mutual funds with customized, practical regulatory compliance and business consulting advice. The firm's philanthropic endeavors include helping to found Bloom360 Learning Community, a nonprofit school for neurodiverse Learners.

Key Points: 
  • Celebrating its 20th anniversary in 2022, management consulting firm Vista360, LLC promotes Lela Harris to Partner and recognizes the success of Bloom360 Learning Community, a nonprofit school for neurodiverse Learners founded and supported by the firm.
  • The firm's philanthropic endeavors include helping to found Bloom360 Learning Community, a nonprofit school for neurodiverse Learners.
  • Lela Harris joined Vista360 in 2016 and has 14 years of investment industry experience.
  • She also helped the firm open Bloom360 Learning Community in 2017 and serves on the Board of Directors, as well as volunteers her time to teach art and mindfulness.

WARF announces annual grant figures

Retrieved on: 
Monday, October 25, 2021
Science, Research, University of Wisconsin–Madison, University, Wisconsin Alumni Research Foundation, Invention, Industry, Computer, Innovation, History, Biomedical Research, Trustee, Faculty, Policy, Badger, Information science, Discovery, Investment, COVID-19, Endowment, Health, Therapy, Warf, Autumn, Education, Morgridge Institute for Research, Ministry of Education (Malaysia), Pharmaceutical industry, Management

MADISON, Wis., Oct. 25, 2021 /PRNewswire/ -- The Wisconsin Alumni Research Foundation (WARF) today announced a total of $216.8 million in support for the University of Wisconsin-Madison research enterprise during the 2021-22 academic year. The figure is WARF's largest annual investment in UW-Madison-based research and education in the foundation's history.

Key Points: 
  • WARF is pleased to be part of the solution through our annual grant, additional facility and pandemic support and our everyday work advancing Badger inventions to market."
  • "WARF was founded over nine decades ago by Professor Steenbock to protect and commercialize inventions from UW-Madison," says Dr. James Berbee, Chair of the WARF Board of Trustees.
  • WARF's annual grant continues a tradition of investing in UW-Madison that dates back almost a century.
  • WARF is home to WARF Accelerator advancing promising university technologies, WARF Therapeutics combining world-renowned research and an industry-focused approach to improve value propositions of drug candidates and WARF Ventures which actively invests in startups with UW-Madison technology over two decades.

WARF announces annual grant figures

Retrieved on: 
Monday, October 25, 2021
Science, Research, University of Wisconsin–Madison, University, Wisconsin Alumni Research Foundation, Invention, Industry, Computer, Innovation, History, Biomedical Research, Trustee, Faculty, Policy, Badger, Information science, Discovery, Investment, COVID-19, Endowment, Health, Therapy, Warf, Autumn, Education, Morgridge Institute for Research, Ministry of Education (Malaysia), Pharmaceutical industry, Management

MADISON, Wis., Oct. 25, 2021 /PRNewswire/ -- The Wisconsin Alumni Research Foundation (WARF) today announced a total of $216.8 million in support for the University of Wisconsin-Madison research enterprise during the 2021-22 academic year. The figure is WARF's largest annual investment in UW-Madison-based research and education in the foundation's history.

Key Points: 
  • WARF is pleased to be part of the solution through our annual grant, additional facility and pandemic support and our everyday work advancing Badger inventions to market."
  • "WARF was founded over nine decades ago by Professor Steenbock to protect and commercialize inventions from UW-Madison," says Dr. James Berbee, Chair of the WARF Board of Trustees.
  • WARF's annual grant continues a tradition of investing in UW-Madison that dates back almost a century.
  • WARF is home to WARF Accelerator advancing promising university technologies, WARF Therapeutics combining world-renowned research and an industry-focused approach to improve value propositions of drug candidates and WARF Ventures which actively invests in startups with UW-Madison technology over two decades.

$175 Million Commitment Helps Launch UW–Madison School of Computer, Data & Information Sciences, Support Transformative Mission

Retrieved on: 
Friday, September 17, 2021
Education, Technology, Software, Continuing, Training, University, Wisconsin Alumni Research Foundation, CDIS, School, Student, Multimedia, Cisco Systems, Computer, Computer Sciences, Faculty, Morgridge Institute for Research, CEO, University, Information science, WARF, University of Washington Information School, LMN, Technology, Information school, LMN Architects, Industry, Pharmaceutical industry, Interior design

View the full release here: https://www.businesswire.com/news/home/20210917005387/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210917005387/en/
    The interior of the planned School of Computer, Data & Information Sciences Building at the University of WisconsinMadison will be the center of the campus computer science community.
  • Image Credit - Kahler Slater and LMN Architects
    CDIS brings together UWMadisons highly ranked Computer Sciences and Statistics departments and the Information School.
  • The School of Computer, Data & Information Sciences is a place where our faculty and students will shape the way technology influences and enriches our lives.
  • Tashia and I hope our commitment will inspire others to see the transformative potential of this project and help get it over the finish line.

$175 million commitment helps launch UW-Madison School of Computer, Data & Information Sciences, support transformative mission

Retrieved on: 
Friday, September 17, 2021
Information, Wisconsin Alumni Research Foundation, CDIS, School, Student, Multimedia, Cisco Systems, Computer, Computer Sciences, Faculty, CEO, University, Information science, WARF, University of Washington Information School, Technology, Information school, Industry, Pharmaceutical industry, Information technology, Management

The School of Computer, Data & Information Sciences will be a new beacon for high tech in a state-of-the-art facility.

Key Points: 
  • The School of Computer, Data & Information Sciences will be a new beacon for high tech in a state-of-the-art facility.
  • CDIS brings together UWMadison's highly ranked Computer Sciences and Statistics departments and the Information School.
  • "The School of Computer, Data & Information Sciences is a place where our faculty and students will shape the way technology influences and enriches our lives.
  • "Tashia and I hope our commitment will inspire others to see the transformative potential of this project and help get it over the finish line."